These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 25069899)

  • 1. Enzymatic glycosylation of the topical antibiotic mupirocin.
    Parajuli P; Pandey RP; Pokhrel AR; Ghimire GP; Sohng JK
    Glycoconj J; 2014 Nov; 31(8):563-72. PubMed ID: 25069899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioconversion of Tetracycline Antibiotics to Novel Glucoside Derivatives by Single-Vessel Multienzymatic Glycosylation.
    Pandey RP; Chu LL; Kim TS; Sohng JK
    J Microbiol Biotechnol; 2018 Feb; 28(2):298-304. PubMed ID: 29212298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficient enzymatic systems for synthesis of novel α-mangostin glycosides exhibiting antibacterial activity against Gram-positive bacteria.
    Le TT; Pandey RP; Gurung RB; Dhakal D; Sohng JK
    Appl Microbiol Biotechnol; 2014 Oct; 98(20):8527-38. PubMed ID: 25038930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucosylation of isoflavonoids in engineered Escherichia coli.
    Pandey RP; Parajuli P; Koirala N; Lee JH; Park YI; Sohng JK
    Mol Cells; 2014 Feb; 37(2):172-7. PubMed ID: 24599002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural basis for the recognition of isoleucyl-adenylate and an antibiotic, mupirocin, by isoleucyl-tRNA synthetase.
    Nakama T; Nureki O; Yokoyama S
    J Biol Chem; 2001 Dec; 276(50):47387-93. PubMed ID: 11584022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro single-vessel enzymatic synthesis of novel Resvera-A glucosides.
    Shin JY; Pandey RP; Jung HY; Chu LL; Park YI; Sohng JK
    Carbohydr Res; 2016 Apr; 424():8-14. PubMed ID: 26918515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enzymatic synthesis of novel phloretin glucosides.
    Pandey RP; Li TF; Kim EH; Yamaguchi T; Park YI; Kim JS; Sohng JK
    Appl Environ Microbiol; 2013 Jun; 79(11):3516-21. PubMed ID: 23542617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selected Mutations Reveal New Intermediates in the Biosynthesis of Mupirocin and the Thiomarinol Antibiotics.
    Gao SS; Wang L; Song Z; Hothersall J; Stevens ER; Connolly J; Winn PJ; Cox RJ; Crump MP; Race PR; Thomas CM; Simpson TJ; Willis CL
    Angew Chem Int Ed Engl; 2017 Mar; 56(14):3930-3934. PubMed ID: 28181382
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Cern A; Connolly KL; Jerse AE; Barenholz Y
    Antimicrob Agents Chemother; 2018 Apr; 62(4):. PubMed ID: 29339382
    [No Abstract]   [Full Text] [Related]  

  • 10. Mechanism of mupirocin transport into sensitive and resistant bacteria.
    Capobianco JO; Doran CC; Goldman RC
    Antimicrob Agents Chemother; 1989 Feb; 33(2):156-63. PubMed ID: 2497702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical relevance of mupirocin resistance in Staphylococcus aureus.
    Hetem DJ; Bonten MJ
    J Hosp Infect; 2013 Dec; 85(4):249-56. PubMed ID: 24144552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Formation of flavone di-O-glucosides using a glycosyltransferase from Bacillus cereus.
    Ahn BC; Kim BG; Jeon YM; Lee EJ; Lim Y; Ahn JH
    J Microbiol Biotechnol; 2009 Apr; 19(4):387-90. PubMed ID: 19420995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced production of nargenicin A(1) and generation of novel glycosylated derivatives.
    Dhakal D; Le TT; Pandey RP; Jha AK; Gurung R; Parajuli P; Pokhrel AR; Yoo JC; Sohng JK
    Appl Biochem Biotechnol; 2015 Mar; 175(6):2934-49. PubMed ID: 25577346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Engineered biosynthesis of glycosylated derivatives of narbomycin and evaluation of their antibacterial activities.
    Han AR; Shinde PB; Park JW; Cho J; Lee SR; Ban YH; Yoo YJ; Kim EJ; Kim E; Park SR; Kim BG; Lee DG; Yoon YJ
    Appl Microbiol Biotechnol; 2012 Feb; 93(3):1147-56. PubMed ID: 21959378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Engineered thiomarinol antibiotics active against MRSA are generated by mutagenesis and mutasynthesis of Pseudoalteromonas SANK73390.
    Murphy AC; Fukuda D; Song Z; Hothersall J; Cox RJ; Willis CL; Thomas CM; Simpson TJ
    Angew Chem Int Ed Engl; 2011 Mar; 50(14):3271-4. PubMed ID: 21381163
    [No Abstract]   [Full Text] [Related]  

  • 16. Phenyltriazole-functionalized sulfamate inhibitors targeting tyrosyl- or isoleucyl-tRNA synthetase.
    De Ruysscher D; Pang L; Mattelaer CA; Nautiyal M; De Graef S; Rozenski J; Strelkov SV; Lescrinier E; Weeks SD; Van Aerschot A
    Bioorg Med Chem; 2020 Aug; 28(15):115580. PubMed ID: 32631562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mupirocin resistance screening of methicillin-resistant Staphylococcus aureus isolates at Madigan Army Medical Center.
    Perkins D; Hogue JS; Fairchok M; Braun L; Viscount HB
    Mil Med; 2008 Jun; 173(6):604-8. PubMed ID: 18595427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mupirocin: biosynthesis, special features and applications of an antibiotic from a gram-negative bacterium.
    Gurney R; Thomas CM
    Appl Microbiol Biotechnol; 2011 Apr; 90(1):11-21. PubMed ID: 21336932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a topical mupirocin spray for antibacterial and wound-healing applications.
    Sritharadol R; Nakpheng T; Wan Sia Heng P; Srichana T
    Drug Dev Ind Pharm; 2017 Oct; 43(10):1715-1728. PubMed ID: 28581830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimicrobial properties of Pseudomonas strains producing the antibiotic mupirocin.
    Matthijs S; Vander Wauven C; Cornu B; Ye L; Cornelis P; Thomas CM; Ongena M
    Res Microbiol; 2014 Oct; 165(8):695-704. PubMed ID: 25303834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.